EMAIL THIS PAGE TO A FRIEND

Toxicology and applied pharmacology

Selectivity of natural, synthetic and environmental estrogens for zebrafish estrogen receptors.


PMID 25106122

Abstract

Zebrafish, Danio rerio, is increasingly used as an animal model to study the effects of pharmaceuticals and environmental estrogens. As most of these estrogens have only been tested on human estrogen receptors (ERs), it is necessary to measure their effects on zebrafish ERs. In humans there are two distinct nuclear ERs (hERα and hERβ), whereas the zebrafish genome encodes three ERs, zfERα and two zfERβs (zfERβ1 and zfERβ2). In this study, we established HeLa-based reporter cell lines stably expressing each of the three zfERs. We first reported that estrogens more efficiently activate the zfERs at 28°C as compared to 37°C, thus reflecting the physiological temperature of zebrafish in wildlife. We then showed significant differences in the ability of agonist and antagonist estrogens to modulate activation of the three zfER isotypes in comparison to hERs. Environmental compounds (bisphenol A, alkylphenols, mycoestrogens) which are hER panagonists and hERβ selective agonists displayed greater potency for zfERα as compared to zfERβs. Among hERα selective synthetic agonists, PPT did not activate zfERα while 16α-LE2 was the most zfERα selective compound. Altogether, these results confirm that all hER ligands control in a similar manner the transcriptional activity of zfERs although significant differences in selectivity were observed among subtypes. The zfER subtype selective ligands that we identified thus represent new valuable tools to dissect the physiological roles of the different zfERs. Finally, our work also points out that care has to be taken in transposing the results obtained using the zebrafish as a model for human physiopathology.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T16403
2,2′,4,4′-Tetrahydroxybenzophenone, 97%
C13H10O5
442840
4,4′-Isopropylidenediphenol, analytical standard
C15H16O2
T176
4-Hydroxytamoxifen, analytical standard, (E) and (Z) isomers (50:50)
C26H29NO2
94873
4-Hydroxytamoxifen, (E) and (Z) isomers (50:50), analytical standard
C26H29NO2
290823
4-tert-Octylphenol, 97%
C14H22O
442858
4-tert-Octylphenol, analytical standard
C14H22O
32881
4-tert-Octylphenol solution, 1 μg/mL in acetone, analytical standard
C14H22O
32879
4-tert-Octylphenol solution, 10 μg/mL in acetone, analytical standard
C14H22O
32467
4-tert-Octylphenol solution, 1000 μg/mL in acetone, analytical standard
C14H22O
239658
Bisphenol A, ≥99%
C15H16O2
42088
Bisphenol A, certified reference material, TraceCERT®
C15H16O2
133027
Bisphenol A, 97%
C15H16O2
E9750
Estrone, ≥99%
C18H22O2
E1274
Estrone, meets USP testing specifications
C18H22O2
46573
Estrone, VETRANAL, analytical standard
C18H22O2
E1700000
Estrone, European Pharmacopoeia (EP) Reference Standard
C18H22O2
1255001
Estrone, United States Pharmacopeia (USP) Reference Standard
C18H22O2
PHR1535
Estrone, Pharmaceutical Secondary Standard; Certified Reference Material
C18H22O2
G6649
Genistein, synthetic, ≥98% (HPLC), powder
C15H10O5
G6776
Genistein, from Glycine max (soybean), ~98% (HPLC)
C15H10O5
92136
Genistein, analytical standard
C15H10O5